Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: a primary care cohort study
<p><strong>Aim:</strong> To determine whether achieving early glycaemic control, and any subsequent glycaemic variability, was associated with any change in the risk of major adverse cardiovascular events (MACE).</p> <p><strong>Materials and Methods</s...
Κύριοι συγγραφείς: | Whyte, MB, Joy, M, Hinton, W, McGovern, A, Hoang, U, van Vlymen, J, Ferreira, F, Mount, J, Munro, N, de Lusignan, S |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Wiley
2022
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Glycaemic trajectories in type 2 diabetes and risk of cardiovascular disease: Exploring the link
ανά: Whyte, MB, κ.ά.
Έκδοση: (2019) -
Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis
ανά: Whyte, M, κ.ά.
Έκδοση: (2019) -
Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
ανά: Martin B Whyte, κ.ά.
Έκδοση: (2019-10-01) -
What predicts early glycaemic control in people with type 2 diabetes?
ανά: McGovern, AP, κ.ά.
Έκδοση: (2017) -
Real world evidence for legacy effect of early glycaemic control in type 2 diabetes on risk of macrovascular disease
ανά: Whyte, M, κ.ά.
Έκδοση: (2017)